Actively Recruiting

Age: 18Years - 90Years
All Genders
NCT05006131

Pancreatic Cancer Screening for At-risk Individuals

Led by Beth Israel Deaconess Medical Center · Updated on 2026-04-23

1395

Participants Needed

1

Research Sites

651 weeks

Total Duration

On this page

Sponsors

B

Beth Israel Deaconess Medical Center

Lead Sponsor

W

Washington University School of Medicine

Collaborating Sponsor

AI-Summary

What this Trial Is About

The investigators' goal is to conduct a prospective multicenter study to evaluate the yield and outcomes of screening of pancreas cancer in individuals who are at-risk for pancreatic cancer. We plan to use International Cancer of the Pancreas Screening (CAPS3) Consortium recommendations to standardize study population, screening methodology, and study outcomes.

CONDITIONS

Official Title

Pancreatic Cancer Screening for At-risk Individuals

Who Can Participate

Age: 18Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals undergoing pancreatic cancer screening according to CAPS3 or updated national guidelines
  • Familial pancreatic cancer kindred with specified family history criteria
  • Patients with genetic susceptibility syndromes including Peutz-Jeghers, FAMMM, HBOC, Lynch syndrome, ATM mutations, or hereditary pancreatitis
  • New-onset diabetes patients older than 50 years with weight loss
  • Patients considered high-risk by their treating physician undergoing screening despite not meeting CAPS3 criteria
Not Eligible

You will not qualify if you...

  • Patients with symptoms suggestive of pancreatic cancer undergoing diagnostic procedures such as EUS or MRCP
  • Patients with acute recurrent pancreatitis or abnormal imaging indicative of pancreatic cancer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

Actively Recruiting

Loading map...

Research Team

R

Roya Dastjerdi, MPH

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here